Irish launch ancillary medicinal substance service to notified bodies
This article was originally published in Clinica
Executive Summary
The Irish Medicines Board (IMB) is now accepting applications from notified bodies (NBs) that need to consult a medical device regulatory authority concerning ancillary medicinal substances used in medical devices.